Congenital myopathies and related disorders
- 1 October 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 15 (5) , 553-561
- https://doi.org/10.1097/00019052-200210000-00006
Abstract
Considerable progress has been made in molecular genetic research and in identifying the underlying pathogenesis of congenital myopathies, with implications for genetic counseling. Therefore an overview of such advances in the last two years is most timely and relevant for a more precise delineation of these disorders. New mutations have been described on the ryanodine receptor gene, including the carboxyl-terminus region, and experimental models developed to explain their role in central core disease. Phenotype-genotype correlations for nemaline myopathy have improved our understanding of those related to ACTA1 gene mutations. In multi-minicore disease, collaborative studies support genetic heterogeneity and autosomal-recessive inheritance. Research on X-linked myotubular myopathies has revealed a high percentage of mothers of sporadic cases as carriers. Although not initially included within the congenital myopathies, desmin-related or myofibrillar myopathies are described here because they are closely related to other congenital myopathies with intracytoplasmic inclusions. Western blot for myotubularin and desmin has been proposed as a useful diagnostic test for both X-linked myotubular myopathy and desmin-related myopathy, and in-vitro and mouse models for the latter have provided insights into its pathogenesis. Several entities still await genetic characterization. Here we focus on clinical features, inheritance, and molecular genetics. Advances in immunohistochemistry and molecular genetics in congenital muscular dystrophies have enriched our knowledge of this heterogeneous group of disorders, leading to more accurate classification and differentiation between the various congenital myopathies.Keywords
This publication has 64 references indexed in Scilit:
- Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasisHuman Molecular Genetics, 2001
- Congenital myopathies and congenital muscular dystrophiesCurrent Opinion in Neurology, 2001
- Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptorHuman Molecular Genetics, 2001
- Congenital MyopathiesBrain Pathology, 2001
- A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathyNeurology, 2000
- An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptorHuman Molecular Genetics, 2000
- Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one familyBrain & Development, 2000
- Ryanodine receptor mutations in malignant hyperthermia and central core diseaseHuman Mutation, 2000
- A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca 2+ release channel function and severe central core diseaseProceedings of the National Academy of Sciences, 1999
- A NEW CONGENITAL NON-PROGRESSIVE MYOPATHYBrain, 1956